GNG10 encodes the gamma-10 subunit of heterotrimeric G proteins, which function as modulators and transducers in transmembrane signaling systems. As part of the G protein complex, GNG10 interacts with beta-1 and beta-2 subunits to facilitate GTPase activity, GDP-GTP exchange, and G-protein coupled receptor signaling 1. GNG10 is involved in diverse physiological processes including erythroid differentiation, where it shows prominent expression in bone marrow-derived erythroid progenitors during beta-globin gene regulation 1, and inflammatory responses, with upregulation detected in peripheral leukocytes during insulin resistance and glucose challenge 2. Disease relevance includes melanoma, where GNG10 harbors somatic mutations at rates comparable to GNAZ, implicating heterotrimeric G proteins broadly in melanoma progression 3. GNG10 has been identified as a prognostic gene in glioma complicated by COVID-19 infection, functioning within the PI3K-Akt signaling pathway and potentially modulated by vitamin D 4. In colorectal cancer, GNG10 acts as an oncogenic driver downstream of the lncRNA CCAT1/miR-4679 regulatory axis, promoting cancer cell proliferation, migration, and invasion 5. Additionally, GNG10 emerged as a biomarker with high discriminatory power (AUC 0.82) for distinguishing active tuberculosis from latent infection in children 6, reflecting its involvement in immune regulation and neutrophil-mediated responses.